BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 26453385)

  • 1. Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin.
    Zanaruddin SN; Yee PS; Hor SY; Kong YH; Ghani WM; Mustafa WM; Zain RB; Prime SS; Rahman ZA; Cheong SC
    PLoS One; 2013; 8(11):e80229. PubMed ID: 24224046
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Krüger K; Grust A; Muallah D; Patenge A; Wikman H; Mesa MM; Knust ES; Sartori A; Smeets R; Kluwe L; Friedrich RE; Burg S
    Anticancer Res; 2024 Jun; 44(6):2369-2376. PubMed ID: 38821622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population.
    Kumar R; Kumar R; Goel H; Kumar S; Ningombam SS; Haider I; Agrawal U; Deo S; Gogia A; Batra A; Sharma A; Mathur S; Ranjan A; Chopra A; Hussain S; Tanwar P
    Cancer Cell Int; 2023 Oct; 23(1):236. PubMed ID: 37821962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
    Starzyńska A; Adamska P; Sejda A; Sakowicz-Burkiewicz M; Adamski ŁJ; Marvaso G; Wychowański P; Jereczek-Fossa BA
    Life (Basel); 2020 Dec; 10(12):. PubMed ID: 33287350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.
    Zheng S; He S; Liang Y; Tan Y; Liu Q; Liu T; Lu X
    Mol Biomed; 2024 Apr; 5(1):13. PubMed ID: 38616230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Profiling of OSCC Patients in an Indian Subset.
    Patel A; Kikani A; Makadiya G; Shah S
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):233-239. PubMed ID: 38285789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Landscape and Computational Screening of the Natural inhibitors against HPV16 E6 Oncoprotein.
    Juneja T; Pandya MD; Shah S
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2461-2469. PubMed ID: 34452559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the
    Starzyńska A; Sejda A; Adamska P; Marvaso G; Sakowicz-Burkiewicz M; Adamski Ł; Jereczek-Fossa BA
    Arch Med Sci; 2021; 17(1):207-217. PubMed ID: 33488873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.
    Michmerhuizen NL; Birkeland AC; Bradford CR; Brenner JC
    Genes Cancer; 2016 May; 7(5-6):182-200. PubMed ID: 27551333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association studies and epigenome-wide association studies go together in cancer control.
    Verma M
    Future Oncol; 2016 Jul; 12(13):1645-64. PubMed ID: 27079684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
    Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deregulation of the PIK3CA oncogene in oral cancer.
    Murugan AK; Munirajan AK; Tsuchida N
    Cancer Lett; 2013 Sep; 338(2):193-203. PubMed ID: 23597702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphoinositide 3-kinase (PI3-K) expression. Tumorigenesis of epithelial carcinoma of the mouth].
    Stahl U; Wenk J; Wagener F; Woenckhaus J; Gamerdinger U; Battmann A; Dreyer T
    Pathologe; 2004 Feb; 25(1):31-7. PubMed ID: 14767610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population.
    Shah S; Shah S; Padh H; Kalia K
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):628-35. PubMed ID: 26453385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
    Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
    Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.
    Kostakis GC; Papadogeorgakis N; Koumaki V; Kamakari S; Koumaki D; Alexandridis C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):e53-8. PubMed ID: 20416519
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.